文献速递传染病防控与疫情报告卫生政策与健康促进

欧洲2022年霍乱病例分离的O1群霍乱弧菌基因组分析

Genomic analysis of Vibrio cholerae O1 isolates from cholera cases, Europe, 2022.
PubMed 文献 · Euro Surveill · 2024-01-01

2022年WHO欧洲区域九国报告51例霍乱病例(2021年仅5例)。对其中49株O1群霍乱弧菌分离株进行基因组分析,46株质量合格基因组均属第七次大流行El Tor谱系(7PET),其中44株中34株属Pre-AFR15亚谱系,该亚谱系可能为2022年全球霍乱病例激增的主要贡献者,未发现异常耐药特征。

要点

  • 2022年WHO欧洲区域报告51例霍乱,2021年仅5例。
  • 46株合格基因组均属7PET谱系,44株中34株为Pre-AFR15亚谱系。
  • 未从46株基因组耐药基因分析中推断出异常耐药谱。

核心结论

  • 2022年WHO欧洲区域国家报告的O1群霍乱弧菌分离株均属第七次大流行El Tor谱系(7PET)。
  • Pre-AFR15亚谱系可能为2022年全球霍乱病例激增的主要贡献者。
  • 高收入国家参考实验室应使用全基因组测序将O1群霍乱弧菌分离株正式归入7PET或非流行谱系。

研究设计与样本

  • 采用微生物基因组学方法研究从51例欧洲病例中回收的49株O1群霍乱弧菌分离株。
  • 利用超过1,450个公开可获得的7PET基因组为这49株分离株提供全球系统发育背景。

主要发现

  • 获得的46株质量合格基因组均属7PET谱系。
  • 除两株外,所有分离株均属基因组Wave 3,并归入三个亚谱系,其中Pre-AFR15占主导(44株中34株)。
  • Pre-AFR15亚谱系对应南亚、中东及东非或南部非洲多国分离株,可能为2022年全球霍乱病例激增的主要贡献者。
  • 从46株基因组的耐药基因内容分析中未推断出异常耐药谱。

临床怎么用

  • 高收入国家参考实验室应使用全基因组测序将O1群霍乱弧菌分离株正式归入7PET或非流行谱系。
  • 基于旅行者分离株的定期协作基因组研究可提供关于流行菌株及其进化的有用信息,尤其涉及耐药性方面。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundThe number of cholera cases reported to the World Health Organization (WHO) in 2022 was more than double that of 2021. Nine countries of the WHO European Region reported 51 cases of cholera in 2022 vs five reported cases in 2021.AimWe aimed to confirm that the Vibrio cholerae O1 isolates reported by WHO European Region countries in 2022 belonged to the seventh pandemic El Tor lineage (7PET). We also studied their virulence, antimicrobial resistance (AMR) determinants and phylogenetic relationships.MethodsWe used microbial genomics to study the 49 V. cholerae O1 isolates recovered from the 51 European cases. We also used > 1,450 publicly available 7PET genomes to provide a global phylogenetic context for these 49 isolates.ResultsAll 46 good-quality genomes obtained belonged to the 7PET lineage. All but two isolates belonged to genomic Wave 3 and were grouped within three sub-lineages, one of which, Pre-AFR15, predominated (34/44). This sub-lineage, corresponding to isolates from several countries in Southern Asia, the Middle East and Eastern or Southern Africa, was probably a major contributor to the global upsurge of cholera cases in 2022. No unusual AMR profiles were inferred from analysis of the AMR gene content of the 46 genomes.ConclusionReference laboratories in high-income countries should use whole genome sequencing to assign V. cholerae O1 isolates formally to the 7PET or non-epidemic lineages. Periodic collaborative genomic studies based on isolates from travellers can provide useful information on the circulating strains and their evolution, particularly as concerns AMR.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Rouard C, Greig DR, Tauhid T, et al. Genomic analysis of Vibrio cholerae O1 isolates from cholera cases, Europe, 2022. Euro Surveill. 2024. PMID: 39239731. doi:10.2807/1560-7917.ES.2024.29.36.2400069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。